PD_2.pdf
PDF 1 MB Posted
- Attached to
- Annual Software License for the Molecular Operating Environment (MOE) without scientific Support. Federal contract opportunity
- Solicitation number
- 75N95024Q00083
About this file
This document is a purchase description for a renewal of software licenses for a fully integrated drug discovery platform. The National Center for Advancing Translational Sciences (NCATS) requires 21 software licenses for the platform from January 1, 2024 through December 31, 2024 as the base period of performance with two optional one-year extensions. Keys for the licenses are to be sent to three specified staff members at NCATS. No further deliverables or reporting are required from the vendor beyond providing access to the discovery platform software. The related federal contract opportunity is a solicitation from the Department of Health and Human Services National Institutes of Health for annual software licenses for the Molecular Operating Environment (MOE) without scientific support.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| D_Section_508_Electronic_Software_standards.pdf | ||
| D_CSS (final).pdf | ||
| D_FAR52.204-24(Nov 2021).pdf | ||
| D_Combined FAR 52.212-4 and Addendum.pdf | ||
| D_NIH Invoice and Payment Instructions.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Please wait...
If this message is not eventually replaced by the proper contents of the document, your PDF viewer may not be able to display this type of document.
You can upgrade to the latest version of Adobe Reader for Windows®, Mac, or Linux® by visiting http://www.adobe.com/go/reader_download.
For more assistance with Adobe Reader visit http://www.adobe.com/go/acrreader.
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc., registered in the United States and other countries. Linux is the registered trademark of Linus Torvalds in the U.S. and other countries.
Purchase Description Statement of Need and Purpose:
Background Information and Objective:
Generic Name of Product:
Purchase Description:
Salient Characteristics:
Quantity:
Delivery Date:
Period of Performance:
Option(s):
9.0.0.2.20101008.1.734229
| ResetButton1: |
| SaveAs: |
| Include a general narrative of the need of the requirement and the desired results.: NCATS is in need of obtaining a renewal for a fully integrated drug discovery platform. |
| Include a brief history of the requirement, the importance of the requirement, and the overall program objectives.: The National Institutes of Health (NIH) is the nation’s leading medical research agency and the primary Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, conducting, supporting and making medical discoveries that improve people’s health and save lives. |
The National Center for Advancing Translational Sciences (NCATS) is a part of the National Institutes of Health (NIH), which mission it is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.
The NCATS Early Translation Branch (ETB) is tasked with identifying and developing novel small molecule leads against a wide spectrum of human disease targets, which it accomplishes by screening thousands of small molecules in collaboration with both intra-and extramural researchers. In pursuit of this goal, the Center has a strong internal transdisciplinary team of scientists who continually discover novel small molecules for application against a wide range of human diseases.
As such, NCATS needs a license for software that allows access to a fully integrated drug discovery platform that will be used by the Informaticist in everyday actions.
| Specify the generic name of the component or system, e.g., freezer, microscope, cell sorter, etc.: Renewal of License for fully integrated drug discovery platform |
| Specify 1) trade name; 2) product’s brand name; 3) manufacturer's name; 4) model, type, catalog, and/or part number(s.): Vendor is responsible for providing access to the discovery platform for one (1) year, starting from January 1, 2024 to December 31, 2024 and two additional options |
Specify the significant, essential physical, functional, performance, or material element(s) (the distinguishing characteristic) of a product, system, component, or service required. Specify the functions that a system or component must perform to meet the Government’s objectives. Include required levels of performance, features or characteristics of the system or component that are essential to meet the government’s objectives. Specify the Government’s minimum acceptable standards.: Vendor is responsible for providing 21 software licenses for the Informatics team.
Keys for licenses to be sent to Sam Michael at michaelsg@mail.nih.gov and Min Shen shenmin@mail.nih.gov , also NCATSHelpDeskSupport@mail.nih.gov, no further deliverable or reporting requirements needed.
| Specify quantity. : 21 software license |
| Specify desired delivery date after receipt of order (30-60 days.): At time of award |
| Specify period of performance for software license, warranty, or maintenance agreements.: The period of performance is as follows: |
01/01/2024 – 12/31/2024 (Base)
Specify if options for additional quantities or options to extend the term of the contract for service agreements.: 01/01/2025 – 12/31/2025 (Option 1) 01/01/2026 – 12/31/2026 (Option 2)
File details come from the government source that posted it. Updated .